This invention relates to the use of 2-methyl-thiazolidine-2,4-dicarboxylic
acid and/or its physiologically tolerable salts as mucolytic agents.
Cette invention concerne l'utilisation de l'acide 2-methyl-thiazolidine-2,4-dicarboxylic et/ou de ses sels physiologiquement tolérables comme agents de mucolytic.